Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/22/2008

Keryx to Host Investor Conference Call on Monday, February 25, 2008 at

8:30am EST

NEW YORK, Feb. 22 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer (the "Company"), today announced its results for the fourth quarter and year ended December 31, 2007.

At December 31, 2007, the Company had cash, cash equivalents, investment securities and interest receivable of $64.7 million, as compared to $125.6 million at December 31, 2006.

The net loss for the fourth quarter ended December 31, 2007 was $29,261,000, or $0.67 per share, compared to a net loss of $18,347,000, or $0.42 per share, for the comparable quarter in 2006, representing an increase in net loss of $10,914,000. The increase in net loss was primarily attributable to a $2,228,000 increase in research and development expenses related to the Company's Sulonex(TM) (sulodexide oral gelcap) pivotal Phase 3 and Phase 4 clinical program, a $4,372,000 increase in expenses related to KRX-0401, a $2,600,000 increase in expenses related to Zerenex, a $446,000 increase in expenses related to the Company's other clinical compounds and a $1,692,000 increase in non-cash compensation expense related to stock option and restricted stock grants.

The net loss for the year ended December 31, 2007 was $90,062,000, or $2.07 per share, compared to a net loss of $73,764,000, or $1.76 per share, for the year ended December 31, 2006, representing an increase in net loss of $16,298,000. The increase in net loss
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
2. Keryx Biopharmaceuticals Announces Additions to Management Team
3. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
8. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
11. Genta Announces Senior Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...ote on an article on "The Final Death Knell of Chi... was on the walls of the demise of Searle due to t...final remaining Searle facilities in Chicago. Sinc...in Chicago. , ,Fast forward two years to another a...thousands of jobs, Chicago,s biotech space to trip...
...t gave about $400,000 worth of software to Lad L...k youth and their families. Rob Busch, enterprise ...reception last Friday at the non-profit,s Synergy ... ,Microsoft,s software donation will be used to up...e, including the computers and software programs u...
...c Foundry posted mixed financial numbers for the e...enue while still posting a net loss. , ,Revenues w...previous fiscal year, with unit sales up 74 percen... new product offerings and increased marketing eff...t, however, and the company posted a loss of $4.2 ...
...sin is to attract the presence of major pharmaceut...focus on its own environment, said a panel assembl... Medical-Devices Association. , ,Part of building ...cting large corporations, said WBMA President and ...nior consultant with Cushman and Wakefields Busine...
Other Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5Panel stresses drawing outside biotech firms to state 2
(Date:9/4/2008)...overed a gene enhancer, known as HACNS1, that may ...opposable human thumb, and possibly also modificat...k on two legs, according to a paper published in ...irst to provide evidence of the existence of human...genes in the human genome. , Dr. Shyam Prabhak...
(Date:9/4/2008)...ch from the University of Cincinnati (UC) implicat...icsbisphenol A (BPA)as a risk factor for metabolic...y study, using fresh human fat tissues, the UC tea...ctin, which is responsible for regulating insulin ...antially higher risk for metabolic syndrome. , ...
(Date:9/4/2008)...ARBOR, N.Y. (Sept. 4, 2008) A variety of organis...e biological rhythms, where the timing and duratio... adjusted to allow them to adapt and survive, even...ecent years, significant advances have been made t...and how they translate into modifications in cellu...
(Date:9/4/2008)...arch is the next great leap in medicine. In the fu...ce a failing heart, or new cells take the place of...m cells from embryonic sources, which opens diffic...entists have been looking to adult human stem cell...ls are now being cultivated from various tissues i...
Breaking Biology News(10 mins):Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Tel Aviv University researchers create new stem cell screening tool 2Indevus Pharmaceuticals To Present at RBC Capital Markets Conference 7668 1Indevus Pharmaceuticals To Present at RBC Capital Markets Conference 7668 2Indevus Pharmaceuticals To Present at RBC Capital Markets Conference 7668 3AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices 7666 1AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices 7666 2New UC Davis study finds physician style and HMO affiliation impact lengths of patient visit 7664 1New UC Davis study finds physician style and HMO affiliation impact lengths of patient visit 7664 2Genes Yield More Clues to Schizophrenia 7662 1Genes Yield More Clues to Schizophrenia 7662 2
... Mice given a relatively new cancer drug can survi...elative of smallpox virus, report scientists suppo...ctious Diseases (NIAID), part of the National Inst...ors, suggest that Gleevec or similar drugs might b...llpox vaccine. The classic smallpox vaccine is mad...
... In this week,s journal Nature, scientists at the ...they have solved one of the "holy grail" puzzles o...ism that insures that the exterior of our bodies i...metrically. , In research with zebra fish, as a mo...s Salk Institute colleagues found that retinoic ac...
... Using a common chemotherapy agent, researchers at...f Pathology and Laboratory Medicine found a way to... cancer, shaking it loose from one location in a c...nother, easier to target area. , The discovery, o...the peer-reviewed journal Molecular Cancer Therape...
... University of Nevada, Reno scientists have ended ...h bark beetles make pheromones: they manufacture t...nts produce and which are often used in perfumes. ... were incapable of making these substances. , "The...romone production," said Gary Blomquist, professor...
Other Biology News:Cancer drug slows poxvirus in mice 2Cancer drug slows poxvirus in mice 3Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 3UCLA cancer researchers shake loose hidden biomarker 2Researchers discover key gene involved in bark beetle pheromone production 2
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds.
...• Human serum is obtained from normal human d...uman Immunodeficiency Virus Antigen (s) (HIV-1Ag),...HIV 1/2), Hepatitis C Virus (HCV), and Nonreactive...eactive by a screening test for syphilis. Serum is...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates.
Values of steady state parameters for enzyme activities are determined.
Biology Products: